Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis

OBJECTIVE: To compare serum levels of the astrocyte biomarker glial fibrillary acidic protein (GFAP) in patients with amyotrophic lateral sclerosis (ALS) and neurologically healthy controls and to analyze the relations between serum GFAP (sGFAP) and phenotype in ALS. METHODS: We studied 114 ALS pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Verde, Federico, Milone, Ilaria, Maranzano, Alessio, Colombo, Eleonora, Torre, Silvia, Solca, Federica, Doretti, Alberto, Gentile, Francesco, Manini, Arianna, Bonetti, Ruggero, Peverelli, Silvia, Messina, Stefano, Maderna, Luca, Morelli, Claudia, Poletti, Barbara, Ratti, Antonia, Silani, Vincenzo, Ticozzi, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852391/
https://www.ncbi.nlm.nih.gov/pubmed/36525477
http://dx.doi.org/10.1002/acn3.51708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852391/
https://www.ncbi.nlm.nih.gov/pubmed/36525477
http://dx.doi.org/10.1002/acn3.51708

Ejemplares similares